Recent Courses

Updates in Psoriatic Arthritis – Highlights from ACR 2016
  • 0.50 AMA PRA Category 1 Credit(s)™ credits
  • 0.50 Non-physician credits
As the number of new and emerging treatment options for patients with psoriatic arthritis (PsA) continues to expand, healthcare providers in dermatology and rheumatology settings are challenged to remain up-to-date. Presentations and publications associated with each major medical meeting yield potentially practice-changing data. This activity...
Severe Asthma and the Primary Care Provider: Identifying Patients and...
  • 1.00 AANP credit
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME-accredited Through Your Patient’s EyesTM program is intended for primary care providers and other clinicians who manage patients with asthma. This educational activity has been designed to highlight issues faced by people living with asthma, including patients’ perspectives on the burdens of severe disease, difficulties related to...
An Update on Scientific Advances and Clinical Strategies in Chronic Obstructive...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
The 2017 American Thoracic Society (ATS) International Conference was held in Washington, DC, May 19–24, 2017. As a leading meeting in respiratory medicine, dedicated to advancing the clinical and scientific understanding of pulmonary diseases, critical illnesses, and sleep-related breathing disorders, the ATS Conference attracts thousands of...
Immunotherapy: The Wave of the Future in Bladder Cancer?
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This article reviews the role of immunotherapy in the treatment of locally advanced and metastatic urothelial cell carcinoma (UC). It describes the basic principles of cancer immunotherapy, as they relate to management of UC, and summarizes clinical data on current and investigational therapeutic approaches. Two immune checkpoint inhibitors are...
Real-world Experience With Neuromuscular Blockade Reversal
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Neuromuscular blocking agents (NMBAs) are used in many surgical procedures and have enabled new surgical advances. The expanded landscape of NMB reversal drugs allows for fast and complete neuromuscular blockade (NMB) reversal and the reduction of postoperative complications from residual block. In the United States, neostigmine/ glycopyrrolate...
Perspectives from the American Academy of Dermatology 2017 Meeting: Clinical...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
After many years of little movement in new therapies for patients with atopic dermatitis (AD), significant growth in researching the pathogenesis of AD has resulted in a better understanding of its causes, which has led to new protein targets for novel monoclonal antibodies (mABs). Often diagnosed in infancy, AD can persist into adulthood,...
Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era...
  • 2.00 AMA PRA Category 1 Credit(s)™ credits
  • 2.00 Non-physician credits
This educational content was derived from the American College of Physicians (ACP) Internal Medicine Meeting 2017 in San Diego, California. This activity will focus on optimized treatment plans for patients with dyslipidemia in the era of PCSK9 inhibitor therapeutics. LDL-C has been identified as an important therapeutic target to prevent the...
Applying New Science to Improve Outcomes for Patients with Multiple Sclerosis
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME program will feature content presented at the the 69th Annual American Academy of Neurology (AAN) Meeting held in Boston, Massachusetts. Three expert faculty will analyze recent therapeutic advances in the treatment and management of patients with multiple sclerosis. The clinical relevance of emerging and emerged trial data will be...
Navigating the Evolving Therapeutic Landscape in Advanced Prostate Cancer
  • 3.00 AMA PRA Category 1 Credit(s)™ credits
  • 3.00 Non-physician credits
Statement of Need and PurposeThe treatment of castration-resistant prostate cancer (CRPC) has undergone a rapid evolution over the last decade. Advances in understanding of the mechanisms of CRPC progression have highlighted several pathways and targets that appear promising to better treat this disease.  A number of new therapies from different...
A Therapeutic Update on the Management of Patients with Atopic Dermatitis
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
After many years of little movement in new therapies for patients with atopic dermatitis (AD), significant growth in researching the pathogenesis of AD has resulted in a better understanding of its causes, which has led to new protein targets for novel monoclonal antibodies (mABs). Often diagnosed in infancy, AD can persist into adulthood,...

Pending Activities

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.